6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
ID: 36E79725R0017Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/bb57253cceae455eabba062faf2996c1/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM, intended for use by various federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The objective of this procurement is to secure a reliable and uninterrupted supply of this medication for a contract period of one year, with the possibility of four additional one-year extensions. This medication is crucial for treating nasal conditions, and the estimated annual requirement is approximately 5,784,828 bottles. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. Interested vendors should direct inquiries to Michael Olszewski at michael.olszewski@va.gov or call 708-786-4966.

    Point(s) of Contact
    708-786-4966Michael Olszewski
    (708) 786-4966
    michael.olszewski@va.gov
    Files
    Title
    Posted
    36E79725R0017_1.docx
    The Department of Veterans Affairs (VA) is preparing to issue Request for Proposal (RFP) 36E79725R0017 for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM. This contract, intended for a variety of federal agencies including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service, aims to secure a consistent supply of the medication for a period of one year, with the option for an additional four one-year extensions. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. The procurement falls under NAICS code 325412, and interested vendors must provide specific product details, including the unique National Drug Code (NDC) associated with their offering. The estimated annual requirement is for approximately 5,784,828 bottles of Fluticasone Spray. Further amendments and details regarding the solicitation will be accessible online, and inquiries should be directed to the designated point of contact, Michael Olszewski.
    Lifecycle
    Title
    Type
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Rituximab and Biosimilars
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) designated as 36E79725R0021 for the procurement of Rituximab and its biosimilars, aimed at ensuring a reliable supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will span one year with four additional one-year options, emphasizing the necessity of maintaining an uninterrupted supply chain for these critical medications. Offerors must provide the exact product names along with unique National Drug Codes (NDC), with estimated annual requirements of 17,858 vials of Rituximab 10mg/ml and 25,111 vials of the 50mg/ml variant. The solicitation is expected to be published around February 17, 2025, with a closing date around March 4, 2025; interested parties should direct inquiries to Deb Fassl at Deborah.Fassl@va.gov.
    6505--Bevacizumab Injection
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to procure Bevacizumab Injections through a Request for Proposal (RFP) designated as 36E79725R0019. This procurement aims to secure an uninterrupted supply of Bevacizumab, a critical pharmaceutical product used in the treatment of various medical conditions, for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four additional one-year option periods, and the estimated annual requirements include various package sizes of Bevacizumab, with a total estimated usage of over 100,000 vials. Interested offerors must submit their proposals by March 4, 2025, at 2:30 PM Central Time, and can direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--Tamsulosin Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Tamsulosin Hydrochloride capsules as part of its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing for a base year and four option years, ensuring compliance with FDA standards and providing a unique 11-digit National Drug Code (NDC) for each product. This procurement is vital for maintaining a consistent supply of necessary pharmaceuticals to federal healthcare facilities, adhering to regulatory standards while ensuring availability and pricing stability. Interested parties must submit their offers by February 24, 2025, at 2:30 PM CST, and can contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.
    6505--Phenytoin SA Capsules (VA-25-00022318)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Phenytoin Sodium Extended 100MG Sustained Action Capsules, designated as solicitation number 36E79725R0016. This unrestricted contract aims to ensure a reliable supply of these essential medications for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with one contract awarded for an initial period of one year and the option for four additional one-year periods. The estimated annual requirement is approximately 16,653 units, highlighting the critical need for uninterrupted supply to support service members and associated organizations. Interested offerors should submit their proposals by March 7, 2025, following the electronic issuance of the RFP on or about February 21, 2025, and may direct inquiries to Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov.
    6505--Baclofen Tablets (VA-25-00026620)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Baclofen Tablets under the solicitation titled "6505--Baclofen Tablets (VA-25-00026620)." The primary objective of this procurement is to establish a reliable source for various strengths of Baclofen tablets, ensuring consistent availability and quality at pre-negotiated prices, while complying with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is crucial for maintaining the pharmaceutical needs of VA facilities, addressing issues such as compliance, backorders, and recalls. Interested offerors must submit their proposals by February 5, 2025, at 2:30 PM CST, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    Prescription-fill services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the VISN 15 Network Contracting Office, is seeking qualified contractors to provide prescription-fill services for eligible veterans at the Harry S. Truman Memorial Veterans’ Hospital (HSTMVH) and its associated community-based outpatient clinics (CBOCs) and Home Based Primary Care (HBPC) program, starting June 1, 2025. The contractor will be responsible for filling and dispensing medications, offering patient counseling, and ensuring compliance with Joint Commission standards while maintaining operations during specified hours. This initiative is crucial for enhancing access to pharmacy services for veterans, thereby prioritizing their health and medication management. Interested parties must submit their responses, including company information and capabilities, to Steve Parrott at stephen.parrott@va.gov by February 7, 2025, at 10:00 AM CST, as this is a Request for Information (RFI) and not a solicitation.
    6505--770-25-1-801-0073 - National CMOP D0286 DORZOLAMIDE -(VA-25-00021409) (VA-25-00021409)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of dorzolamide hydrochloride ophthalmic solution under the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The primary objective is to acquire this pharmaceutical product in various quantities, ensuring compliance with specific contract terms, delivery standards, and regulatory requirements, including adherence to the Drug Supply Chain Security Act (DSCSA). This procurement is crucial for maintaining the quality and availability of essential medications for veterans' healthcare needs. Interested vendors must submit their quotes by January 30, 2025, at 3:00 PM Central Time, and can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further information.
    National CMOP CHLORHEXIDINE GLUCONATE
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting quotes for the procurement of Chlorhexidine Gluconate 4% Top Liquid (120ML) through RFQ 36C77025Q0104, aimed at supplying various VA Consolidated Mail Outpatient Pharmacy (CMOP) facilities. Vendors are required to submit their quotes by January 31, 2025, at 4:00 PM CST, along with necessary documentation including a signed solicitation cover page, an Excel pricing schedule, and proof of a valid State Wholesale Distributor License. This procurement is critical for ensuring the availability of pharmaceuticals that meet the healthcare needs of veterans, with strict compliance to federal regulations and quality standards mandated throughout the process. Interested vendors can reach out to Sarah Fry at sarah.fry2@va.gov or call 913-758-9935 for further inquiries.
    6505--Carbidopa/Levodopa SA Tablet
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking pharmaceutical suppliers to establish a national contract for the provision of Carbidopa/Levodopa SA tablets through its Pharmaceutical Prime Vendor program. The Request for Proposal (RFP) outlines specific requirements for potential contractors, including pricing structures for the base year and four option years, compliance with the Drug Supply Chain Security Act, and the necessity for Good Manufacturing Practices (cGMP) status. This procurement is crucial for ensuring a reliable supply of essential medications for veteran and military healthcare systems across the nation. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details regarding the proposal submission process and deadlines.
    6515--Pharmacy Management System ScriptPro Brand name or Equal
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of a ScriptPro Pharmacy Management System or an equivalent solution, as outlined in the combined synopsis/solicitation RFQ 36C26225Q0148. This procurement aims to enhance pharmacy management capabilities across various Veterans Integrated Service Network (VISN) 22 medical facilities and clinics, ensuring high-quality healthcare service delivery through reliable technological advancements. Interested vendors are encouraged to participate, particularly small businesses, including those owned by veterans and women, with bids due by February 4, 2025, at 7:00 AM PST. For inquiries, potential bidders should contact Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.